BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 7.4% in October

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 79,800 shares, a decrease of 7.4% from the September 30th total of 86,200 shares. Based on an average daily trading volume, of 195,000 shares, the short-interest ratio is presently 0.4 days.

Insider Transactions at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. bought 27,148 shares of the business’s stock in a transaction that occurred on Tuesday, September 17th. The stock was bought at an average cost of 15.93 per share, for a total transaction of 432,467.64. Following the completion of the transaction, the insider now owns 20,565,579 shares of the company’s stock, valued at approximately 327,609,673.47. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have purchased 99,630 shares of company stock valued at $1,585,113 in the last quarter.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in BMEZ. Dakota Wealth Management grew its stake in shares of BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock worth $357,000 after purchasing an additional 4,267 shares during the last quarter. Brown Lisle Cummings Inc. increased its stake in shares of BlackRock Health Sciences Term Trust by 6.2% during the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after buying an additional 2,128 shares during the period. Sanctuary Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust during the second quarter valued at approximately $3,179,000. Quarry LP lifted its stake in BlackRock Health Sciences Term Trust by 304.9% in the second quarter. Quarry LP now owns 98,886 shares of the company’s stock worth $1,519,000 after acquiring an additional 74,463 shares during the period. Finally, Almitas Capital LLC lifted its stake in BlackRock Health Sciences Term Trust by 89.3% in the second quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after acquiring an additional 831,025 shares during the period.

BlackRock Health Sciences Term Trust Stock Down 0.6 %

Shares of BMEZ traded down 0.09 during trading hours on Thursday, hitting 15.43. The company had a trading volume of 227,200 shares, compared to its average volume of 265,695. BlackRock Health Sciences Term Trust has a 52-week low of 12.93 and a 52-week high of 16.59. The stock’s 50 day moving average price is 15.83 and its 200 day moving average price is 15.48.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be paid a dividend of $0.176 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.69%. The ex-dividend date of this dividend is Tuesday, October 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.